Aeonose™ Tuberculosis Test
Pulmonary Tuberculosis Detection
Clinical ValidationActive
Key Facts
Indication
Pulmonary Tuberculosis Detection
Phase
Clinical Validation
Status
Active
Company
About The eNose Company
The eNose Company's mission is to transform diagnostics through its portable, non-invasive Aeonose™ technology, which analyzes breath to detect diseases like lung cancer and tuberculosis within minutes. Key achievements include CE-marking for its device, multiple published clinical studies, and a public listing to fund commercialization. Its strategy is to validate its platform across multiple high-burden indications, securing regulatory approvals and building partnerships for global deployment in screening and triage settings.
View full company profile